MedTrace Logo

Regulatory B Cells and Chronic Immune Thrombocytopenia

NCT02891109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2016-09-07

No results posted yet for this study

Summary

The chronic immune thrombopenia is an autoimmune disease caused by B cells. These cells produce anti platelets and megakaryocytes antibodies. Some B cells, named regulatory B cells, are known to control other cells. Their action in chronic immune thrombopenia is actually unknown.

Conditions

  • Purpura, Thrombocytopenic, Idiopathic
  • Regulatory B Cells

Interventions

BIOLOGICAL

Biological tests

From the blood: B and T cells extraction then co-culture B and T cells and characterization of lymphocytes by flow cytometry

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Christophe Jamin, PhD · CHRU de Brest

  • Lenaig Le Clech, MD · CHRU Brest

  • Brigitte Pan-Petesh, MD · CHRU Brest

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02891109 on ClinicalTrials.gov